Harbin invests $4.8b in health industry
Updated : 2014-12-19
By ( chinadaily.com.cn )
The city of Harbin, capital of Northeast China’s Heilongjiang province, planned an investment of 30 billion yuan ($4.8b) in the bio-pharmaceutical industry for the following three years as Harbin was approved by the central government to be a pilot city developing the bio-pharmaceutical industrial cluster this October.
The investment will focus on developing a manufacturing center for innovative products, business centers and R&D institutions in the bio-pharmaceutical industry.
According to statistics, the bio-pharmaceutical industry in Harbin has developed rapidly with sales revenue reaching 31.8 billion yuan in 2013, accounting for 78.3 percent of the total revenue of Heilongjiang province.
Harbin regained the honorary title of "National Civilized City" on Aug 21.
Harbin Economic and Development Zone recently issued measures for the innovative development of the industrial chain.
The Harbin area of China (Heilongjiang) Pilot Free Trade Zone recently moved to streamline its small business licensing regulations to help stimulate the zone’s economy.
Heilongjiang province will leverage all its formidable array of natural advantages to develop its popular winter tourism.